Advertisement

Ligand-Based Designing of Natural Products

  • Vandana Singh
  • Deepak Kumar
  • Sheemona Chowdhary
  • Kunal Maniar
  • Meenu Narwal
  • Rajasri Bhattacharyya
  • Dibyajyoti Banerjee
Chapter

Abstract

Cancer is the second leading cause of mortality according to the current WHO report, which states that 30–50% of cancer cases can be prevented by maintaining a healthy lifestyle. One of the ways to maintain a healthy lifestyle is by consumption of healthy food containing antioxidant molecules and enzymes. Curcumin and polyphenolic compounds are now proven as anticarcinogenic molecules. The structures of these molecules are the reason for their anticarcinogenic property. There are many compounds available in nature that may be used as anticancer or antioxidant molecules. Some of these molecules have similar chemical structures and some have different structures. Moreover, in the absence of the known 3D structure of the natural compound, design and optimization of lead molecules are based on physicochemical properties and quantitative structure activity relationships. In this chapter, ligand-based designing of naturally available anticarcinogenic molecules is discussed.

Keywords

Phytochemicals Cancer Computer-aided drug design and discovery Structure-based method Ligand-based method Chemoprevention 

Abbreviations

EGCG

Epigallocatechin gallate

GSH

Reduced glutathione

GST

Glutathione-S-transferase

LPO

Lipid peroxidation

QSAR

Quantitative structure activity relationship

ROS

Reactive oxygen species

SOD

Superoxide dismutase

References

  1. Anderson AC (2003) The process of structure-based drug design. Chem Biol 10:787–797CrossRefGoogle Scholar
  2. Baldi A (2010) Computational approaches for drug design and discovery: an overview. Syst Rev Pharm 1:99CrossRefGoogle Scholar
  3. Barker HE, Paget JT, Khan AA, Harrington KJ (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15:409CrossRefGoogle Scholar
  4. Boeing H, Bechthold A, Bub A, Ellinger S, Haller D, Kroke A, Leschik-Bonnet E, Müller MJ, Oberritter H, Schulze M, Stehle P (2012) Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr 51:637–663CrossRefGoogle Scholar
  5. Borek C (2004) Dietary antioxidants and human cancer. Integr Cancer Ther 3:333–341CrossRefGoogle Scholar
  6. Cabrera C, Artacho R, Giménez R (2006) Beneficial effects of green tea – a review. J Am Coll Nutr 25:79–99CrossRefGoogle Scholar
  7. Cohen MM (2014) Tulsi-Ocimum sanctum: a herb for all reasons. J Ayurveda Integr Med 5:251CrossRefGoogle Scholar
  8. Cragg GM (1998) Paclitaxel (Taxol®): a success story with valuable lessons for natural product drug discovery and development. Med Res Rev 18:315–331CrossRefGoogle Scholar
  9. Demain AL, Vaishnav P (2011) Natural products for cancer chemotherapy. Microb Biotechnol 4:687–699CrossRefGoogle Scholar
  10. Devi PU (2004) Basics of carcinogenesis. Health Adm 17:16–24Google Scholar
  11. Du GJ, Zhang Z, Wen XD, Yu C, Calway T, Yuan CS, Wang CZ (2012) Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients 4:1679–1691CrossRefGoogle Scholar
  12. Fantini M, Benvenuto M, Masuelli L, Frajese GV, Tresoldi I, Modesti A, Bei R (2015) In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int J Mol Sci 16:9236–9282CrossRefGoogle Scholar
  13. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2008) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRefGoogle Scholar
  14. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H (2004) Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappaB and induction of apoptosis. Oncogene 23:2507CrossRefGoogle Scholar
  15. Hall EJ, Giaccia AJ (2006) Radiobiology for the radiologist. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  16. Hosseini A, Ghorbani A (2015) Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomedicine 5:84Google Scholar
  17. Huang WY, Cai YZ, Zhang Y (2009) Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer 62:1–20CrossRefGoogle Scholar
  18. Hutchinson E (2001) Alfred Knudson and his two-hit hypothesis. Lancet Oncol 2:642–645CrossRefGoogle Scholar
  19. Leelananda SP, Lindert S (2016) Computational methods in drug discovery. Beilstein J Org Chem 12:2694CrossRefGoogle Scholar
  20. Liu Y, Wu YM, Zhang PY (2015) Protective effects of curcumin and quercetin during benzo (a) pyrene induced lung carcinogenesis in mice. Eur Rev Med Pharmacol Sci 19:1736–1743PubMedGoogle Scholar
  21. Lobo V, Patil A, Phatak A, Chandra N (2010) Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev 4:118CrossRefGoogle Scholar
  22. Lounnas V, Ritschel T, Kelder J, McGuire R, Bywater RP, Foloppe N (2013) Current progress in structure-based rational drug design marks a new mindset in drug discovery. Comput Struct Biotechnol J 5:e201302011CrossRefGoogle Scholar
  23. Martis EA, Somani RR (2012, May 23) Drug designing, discovery and development techniques. In: Basnet P (ed) Promising pharmaceuticals. IntechOpen, London. https://doi.org/10.5772/38948. Available from: https://www.intechopen.com/books/promisingpharmaceuticals/drug-designing-discovery-anddevelopment-techniques Google Scholar
  24. Menon VP, Sudheer AR (2007) Antioxidant and anti-inflammatory properties of curcumin. In: Aggarwal BB, Surh YJ, Shishodia S (eds) The molecular targets and therapeutic uses of Urcumin in health and disease. Springer, Texas, pp 105–125CrossRefGoogle Scholar
  25. Middleton E Jr, Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673–751PubMedGoogle Scholar
  26. Oliveira PA, Colaço A, Chaves R, Guedes-Pinto H, De-La-Cruz P, Luis F, Lopes C (2007) Chemical carcinogenesis. An Acad Bras Cienc 79:593–616CrossRefGoogle Scholar
  27. Pitot HC (1993) The molecular biology of carcinogenesis. Cancer 72(3 Suppl):962–970CrossRefGoogle Scholar
  28. Podolskiy DI, Gladyshev VN (2016) Intrinsic versus extrinsic cancer risk factors and aging. Trends Mol Med 22:833–834CrossRefGoogle Scholar
  29. Prada-Gracia D, Huerta-Yépez S, Moreno-Vargas LM (2016) Application of computational methods for anticancer drug discovery, design, and optimization. Bol Médico Hosp Infantil Méx (Engl Ed) 73:411–423Google Scholar
  30. Rahman HS (2016) Natural products for cancer therapy. Dual Diagn Open Acc 1:15CrossRefGoogle Scholar
  31. Rajesh E, Sankari LS, Malathi L, Krupaa JR (2015) Naturally occurring products in cancer therapy. J Pharm Bioallied Sci 7(Suppl 1):S181PubMedPubMedCentralGoogle Scholar
  32. Surh YJ, Chun KS (2007) Cancer chemopreventive effects of curcumin. In: Aggarwal BB, Surh YJ, Shishodia S (eds) The molecular targets and therapeutic uses of urcumin in health and disease. Springer, London, pp 149–172CrossRefGoogle Scholar
  33. Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275–292CrossRefGoogle Scholar
  34. Verma J, Khedkar VM, Coutinho EC (2010) 3D-QSAR in drug design-a review. Curr Top Med Chem 10:95–115CrossRefGoogle Scholar
  35. Xue L, Bajorath J (2000) Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Comb Chem High Throughput Screen 3:363–372CrossRefGoogle Scholar
  36. Yu HB, Pan CE, Wu WJ, Zhao SH, Zhang HF (2008) Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells. Zhong Xi Yi Jie He Xue Bao 6:270–273CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Vandana Singh
    • 1
  • Deepak Kumar
    • 1
  • Sheemona Chowdhary
    • 1
  • Kunal Maniar
    • 2
  • Meenu Narwal
    • 3
  • Rajasri Bhattacharyya
    • 1
  • Dibyajyoti Banerjee
    • 1
  1. 1.Department of Experimental Medicine & BiotechnologyPostgraduate Institute of Medical Education & ResearchChandigarhIndia
  2. 2.Department of PharmacologyPostgraduate Institute of Medical Education & ResearchChandigarhIndia
  3. 3.Department of BiotechnologyMaharishi Markandeshwar (Deemed to be University)AmbalaIndia

Personalised recommendations